Use of doxapram to increase respirations without a concomitant increase in intracranial pressure.
We treated a brain-damaged 8-month-old male with iv doxapram in order to discontinue mechanical ventilation. We were able to monitor intracranial pressure (ICP) throughout the course of doxapram via an ICP monitor. Despite normal and then excessive PaCO2, the patient's spontaneous respiratory rate remained nil before doxapram treatment. However, after an iv bolus dose followed by a maintenance drip, the patient's spontaneous respiratory rate increased while his ICP remained at baseline or slightly less than baseline, thereby allowing mechanical ventilation to be discontinued.
Fisher
B
B
Department of Anesthesia/Critical Care, Children's Hospital, San Diego, CA 92123.
Rodarte
A
A
D001925:Brain Damage, Chronic / Q000628:therapy; D004315:Doxapram / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007427:Intracranial Pressure / Q000187:drug effects*; D008297:Male; D012119:Respiration / Q000187:drug effects*; D012121:Respiration, Artificial; D012125:Respiratory Center / Q000187:drug effects; D013268:Stimulation, Chemical
D004315:Doxapram